Decoy Therapeutics’ Novel Inhibitors Show Promise Against Measles
Decoy Therapeutics, a preclinical biopharmaceutical company, has announced that its antiviral drug candidates, designed using its IMP3ACT™ platform, have...
Acu193 Alzheimer’s Trial Enrollment Complete
Acumen Pharmaceuticals has completed enrollment in its Phase 2 ALTITUDE-AD trial of sabirnetug (ACU193) for early-stage Alzheimer’s diseaseAlzheimer’s disease....
City of Hope & Calidi Biotherapeutics Phase 1 Trial Update on CLD-101
Calidi Biotherapeutics and City of Hope announced positive progress in a Phase 1 clinical trial for CLD-101, a neural...
Pleco PTX-252 Shows Promise in AML FDA Meeting
Pleco Therapeutics, a clinical-stage biopharmaceutical company, has received positive feedback from the FDA regarding its Investigational New Drug (IND)...
ABpro Announces Preclinical Data for Tetravalent Bispecific HER2xCD3 T-Cell Engager at AACR 2025
Abpro Holdings announced preclinical data for its HER2 x CD3 T-cell engager, ABP-102/CT-P72, will be presented at the American...
Quanta’s QTX3544: A Powerful New Oral Multi-KRAS Inhibitor
Quanta Therapeutics will present data on QTX3544, an oral, G12V-preferring, multi-KRAS inhibitor, at the 2025 AACR Annual Meeting. QTX3544...
Bolt Biotherapeutics Presents Promising BDC-1042 Data at AACR 2025
Bolt Biotherapeutics will present Phase 1 clinical trial data for BDC-3042, a dectin-2 agonist antibody targeting tumor-associated macrophages (TAMs),...
Polyrizon’s Pioneering Epilepsy Rescue Treatment Shows Promising Preclinical Results
Polyrizon Ltd. has initiated preclinical studies for intranasal delivery of benzodiazepines (BZDs) using its proprietary Trap and Target™ platform....
Corvus Pharmaceuticals 2024 Financial Results
Corvus Pharmaceuticals provided a business update and announced its financial results for the fourth quarter and year ending December...
Wrapsody CIE 12-Month Efficacy Results Released
Merit Medical Systems announced positive six and twelve-month results from the randomized arm of its WAVE trial, studying the...